{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:22:26Z","timestamp":1791397346635,"version":"4.3.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T00:00:00Z","timestamp":1487289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T00:00:00Z","timestamp":1487289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s10552-017-0870-6","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T17:10:57Z","timestamp":1487351457000},"page":"203-214","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Disease burden of human papillomavirus infection in the Netherlands, 1989\u20132014: the gap between females and males is diminishing"],"prefix":"10.1007","volume":"28","author":[{"given":"Scott A.","family":"McDonald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venetia","family":"Qendri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Berkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester E.","family":"de Melker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes A.","family":"Bogaards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,17]]},"reference":[{"key":"870_CR1","unstructured":"The PapillomaVirus Episteme (PaVE). http:\/\/pave.niaid.nih.gov\/. Accessed 20 May 2016"},{"issue":"Suppl 3","key":"870_CR2","first-page":"110","volume":"24","author":"N Munoz","year":"2006","unstructured":"Munoz N, Castellsague X, de Gonzalez AB, Gissmann L (2006) Chap. 1: HPV in the etiology of human cancer. Vaccine 24(Suppl 3):1\u201310","journal-title":"Vaccine"},{"issue":"1","key":"870_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2982","volume":"11","author":"CR Leemans","year":"2011","unstructured":"Leemans CR, Braakhuis BJ, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11(1):9\u201322","journal-title":"Nat Rev Cancer"},{"key":"870_CR4","doi-asserted-by":"publisher","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","volume":"4","author":"M Plummer","year":"2016","unstructured":"Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S (2016) Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health 4:e609\u2013e616","journal-title":"Lancet Glob Health"},{"key":"870_CR5","unstructured":"European Medicines Agency (EMA). http:\/\/www.ema.europa.eu\/. Accessed 20 May 2016"},{"key":"870_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/1743-422X-10-137","volume":"10","author":"MG Hawkins","year":"2013","unstructured":"Hawkins MG, Winder DM, Ball SL, Vaughan K, Sonnex C, Stanley MA, Sterling JC, Goon PK (2013) Detection of specific HPV subtypes responsible for the pathogenesis of condylomata acuminata. Virol J 10:137","journal-title":"Virol J"},{"issue":"8","key":"870_CR7","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1405044","volume":"372","author":"EA Joura","year":"2015","unstructured":"Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, Moreira ED Jr, Ngan Y, Petersen LK, Lazcano-Ponce E et al (2015) A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 372(8):711\u2013723","journal-title":"N Engl J Med"},{"key":"870_CR8","doi-asserted-by":"crossref","unstructured":"zur Hausen H (1977) Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol 78:1\u201330","DOI":"10.1007\/978-3-642-66800-5_1"},{"issue":"1","key":"870_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12\u201319","journal-title":"J Pathol"},{"issue":"4 Suppl 1","key":"870_CR10","first-page":"51","volume":"39","author":"E Sinisgalli","year":"2015","unstructured":"Sinisgalli E, Bellini I, Indiani L, Sala A, Bechini A, Bonanni P, Boccalini S (2015) HPV vaccination for boys? A systematic review of economic studies. Epidemiol Prev 39(4 Suppl 1):51\u201358","journal-title":"Epidemiol Prev"},{"issue":"1","key":"870_CR11","doi-asserted-by":"publisher","first-page":"djv282","DOI":"10.1093\/jnci\/djv282","volume":"108","author":"M Brisson","year":"2016","unstructured":"Brisson M, Laprise JF, Chesson HW, Drolet M, Malagon T, Boily MC, Markowitz LE (2016) Health and economic impact of switching from a 4-valent to a 9-valent HPV vaccination program in the United States. J Natl Cancer Inst 108(1):djv282","journal-title":"J Natl Cancer Inst"},{"key":"870_CR12","doi-asserted-by":"publisher","first-page":"h2016","DOI":"10.1136\/bmj.h2016","volume":"350","author":"JA Bogaards","year":"2015","unstructured":"Bogaards JA, Wallinga J, Brakenhoff RH, Meijer CJ, Berkhof J (2015) Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis. Bmj 350:h2016","journal-title":"Bmj"},{"issue":"9576","key":"870_CR13","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60852-6","volume":"369","author":"KA Ault","year":"2007","unstructured":"Ault KA (2007) Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet 369(9576):1861\u20131868","journal-title":"Lancet"},{"issue":"9686","key":"870_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","volume":"374","author":"J Paavonen","year":"2009","unstructured":"Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR et al (2009) Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 374(9686):301\u2013314","journal-title":"Lancet"},{"issue":"5","key":"870_CR15","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1056\/NEJMoa0909537","volume":"364","author":"AR Giuliano","year":"2011","unstructured":"Giuliano AR, Palefsky JM, Goldstone S, Moreira ED Jr, Penny ME, Aranda C, Vardas E, Moi H, Jessen H, Hillman R et al (2011) Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med 364(5):401\u2013411","journal-title":"N Engl J Med"},{"issue":"17","key":"870_CR16","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","volume":"365","author":"JM Palefsky","year":"2011","unstructured":"Palefsky JM, Giuliano AR, Goldstone S, Moreira ED Jr, Aranda C, Jessen H, Hillman R, Ferris D, Coutlee F, Stoler MH et al (2011) HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 365(17):1576\u20131585","journal-title":"N Engl J Med"},{"issue":"4","key":"870_CR17","doi-asserted-by":"publisher","first-page":"e1001205","DOI":"10.1371\/journal.pmed.1001205","volume":"9","author":"ME Kretzschmar","year":"2012","unstructured":"Kretzschmar ME, Mangen M-J, Pinheiro P, Jahn B, F\u00e8vre EM, Longhi S, Lai T, Havelaar AH, Stein C, Cassini A et al (2012) New methodology for estimating the burden of communicable diseases in Europe. PLoS Med 9(4):e1001205","journal-title":"PLoS Med"},{"issue":"3","key":"870_CR18","first-page":"429","volume":"72","author":"CJ Murray","year":"1994","unstructured":"Murray CJ (1994) Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ 72(3):429\u2013445","journal-title":"Bull World Health Organ"},{"key":"870_CR19","unstructured":"Netherlands Cancer Registry (NCR): http:\/\/www.cijfersoverkanker.nl\/. Accessed 17 Feb 2016"},{"issue":"4","key":"870_CR20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/EDE.0b013e31821d107b","volume":"22","author":"JA Bogaards","year":"2011","unstructured":"Bogaards JA, Coupe VM, Xiridou M, Meijer CJ, Wallinga J, Berkhof J (2011) Long-term impact of human papillomavirus vaccination on infection rates, cervical abnormalities, and cancer incidence. Epidemiology 22(4):505\u2013515","journal-title":"Epidemiology"},{"issue":"3","key":"870_CR21","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00038-014-0553-y","volume":"59","author":"B Devleesschauwer","year":"2014","unstructured":"Devleesschauwer B, Havelaar AH, Maertens de Noordhout C, Haagsma JA, Praet N, Dorny P, Duchateau L, Torgerson PR, Van Oyen H, Speybroeck N (2014) DALY calculation in practice: a stepwise approach. Int J Public Health 59(3):571\u2013574","journal-title":"Int J Public Health"},{"issue":"1","key":"870_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00038-008-8025-x","volume":"54","author":"L Perez","year":"2009","unstructured":"Perez L, Kunzli N (2009) From measures of effects to measures of potential impact. Int J Public Health 54(1):45\u201348","journal-title":"Int J Public Health"},{"issue":"7","key":"870_CR23","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1002\/ijc.27821","volume":"132","author":"MM Rietbergen","year":"2013","unstructured":"Rietbergen MM, Leemans CR, Bloemena E, Heideman DA, Braakhuis BJ, Hesselink AT, Witte BI, Baatenburg de Jong RJ, Meijer CJ, Snijders PJ et al (2013) Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm. Int J Cancer 132(7):1565\u20131571","journal-title":"Int J Cancer"},{"issue":"12","key":"870_CR24","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.oraloncology.2012.06.019","volume":"48","author":"MA O\u2019Rorke","year":"2012","unstructured":"O\u2019Rorke MA, Ellison MV, Murray LJ, Moran M, James J, Anderson LA (2012) Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol 48(12):1191\u20131201","journal-title":"Oral Oncol"},{"key":"870_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1471-2288-12-125","volume":"12","author":"I Soerjomataram","year":"2012","unstructured":"Soerjomataram I, Lortet-Tieulent J, Ferlay J, Forman D, Mathers C, Parkin DM, Bray F (2012) Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer. BMC Med Res Methodol 12:125","journal-title":"BMC Med Res Methodol"},{"issue":"9856","key":"870_CR26","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/S0140-6736(12)60919-2","volume":"380","author":"I Soerjomataram","year":"2012","unstructured":"Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, Bray F (2012) Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. The Lancet 380(9856):1840\u20131850","journal-title":"The Lancet"},{"key":"870_CR27","unstructured":"Statistics Netherlands (CBS) (2015) Life expectancy; sex and age, from 1950 [Levensverwachting; geslacht en leeftijd, vanaf 1950]. CBS, Voorburg. http:\/\/statline.cbs.nl\/"},{"key":"870_CR28","volume-title":"The Victorian burden of disease study: mortality and morbidity in 2001","author":"Department of Human Services (DHS)","year":"2005","unstructured":"Department of Human Services (DHS) (2005) The Victorian burden of disease study: mortality and morbidity in 2001. Department of Human Services, Melbourne"},{"issue":"2","key":"870_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/pubmed\/fdr093","volume":"34","author":"N Jayatilleke","year":"2012","unstructured":"Jayatilleke N, Pashayan N, Powles JW (2012) Burden of disease due to cancer in England and Wales. J Public Health (Oxf) 34(2):287\u2013295","journal-title":"J Public Health (Oxf)"},{"issue":"25","key":"870_CR30","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1002\/sim.3680","volume":"28","author":"D Lunn","year":"2009","unstructured":"Lunn D, Spiegelhalter D, Thomas A, Best N (2009) The BUGS project: Evolution, critique and future directions. Stat Med 28(25):3049\u20133067","journal-title":"Stat Med"},{"issue":"1","key":"870_CR31","first-page":"12","volume":"6","author":"A Thomas","year":"2006","unstructured":"Thomas A, O\u2019Hara B, Ligges U, Sturtz S (2006) Making BUGS Open. R News 6(1):12\u201317","journal-title":"R News"},{"key":"870_CR32","volume-title":"R: A language and environment for statistical computing","author":"R Development Core Team","year":"2014","unstructured":"R Development Core Team (2014) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna"},{"issue":"13","key":"870_CR33","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/1097-0258(20000715)19:13<1741::AID-SIM496>3.0.CO;2-O","volume":"19","author":"T Dyba","year":"2000","unstructured":"Dyba T, Hakulinen T (2000) Comparison of different approaches to incidence prediction based on simple interpolation techniques. Stat Med 19(13):1741\u20131752","journal-title":"Stat Med"},{"issue":"9","key":"870_CR34","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1002\/ijc.25553","volume":"128","author":"IM de Kok","year":"2011","unstructured":"de Kok IM, van der Aa MA, van Ballegooijen M, Siesling S, Karim-Kos HE, van Kemenade FJ, Coebergh JW (2011) Trends in cervical cancer in the Netherlands until 2007: has the bottom been reached? Int J Cancer 128(9):2174\u20132181","journal-title":"Int J Cancer"},{"issue":"9","key":"870_CR35","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1002\/ijc.25211","volume":"127","author":"J Berkhof","year":"2010","unstructured":"Berkhof J, Coupe VM, Bogaards JA, van Kemenade FJ, Helmerhorst TJ, Snijders PJ, Meijer CJ (2010) The health and economic effects of HPV DNA screening in The Netherlands. Int J Cancer 127(9):2147\u20132158","journal-title":"Int J Cancer"},{"key":"870_CR36","unstructured":"Centre for Infectious Disease Control, RIVM (2015) HPV vaccination in the Netherlands. RIVM, Bilthoven. http:\/\/rivm.nl\/Documenten_en_publicaties\/Algemeen_Actueel\/Uitgaven\/Infectieziekten\/Rijksvaccinatieprogramma\/HPV_vaccinatie\/HPV_vaccination_in_the_Netherlands. Accessed 27 June 2016"},{"issue":"Suppl 1","key":"870_CR37","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1007\/s12105-012-0377-0","volume":"6","author":"AK Chaturvedi","year":"2012","unstructured":"Chaturvedi AK (2012) Epidemiology and clinical aspects of HPV in head and neck cancers. Head Neck Pathol 6(Suppl 1):S16\u2013S24","journal-title":"Head Neck Pathol"},{"issue":"32","key":"870_CR38","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","volume":"29","author":"AK Chaturvedi","year":"2011","unstructured":"Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W et al (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29(32):4294\u20134301","journal-title":"J Clin Oncol"},{"issue":"8","key":"870_CR39","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S1470-2045(10)70017-6","volume":"11","author":"S Marur","year":"2010","unstructured":"Marur S, D\u2019Souza G, Westra WH, Forastiere AA (2010) HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 11(8):781\u2013789","journal-title":"Lancet Oncol"},{"issue":"10","key":"870_CR40","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.oraloncology.2015.06.011","volume":"51","author":"HS van Monsjou","year":"2015","unstructured":"van Monsjou HS, Schaapveld M, van den Brekel MW, Balm AJ (2015) The epidemiology of head and neck squamous cell carcinoma in The Netherlands during the era of HPV-related oropharyngeal squamous cell carcinoma. Is there really evidence for a change? Oral Oncol 51(10):901\u2013907","journal-title":"Oral Oncol"},{"issue":"7","key":"870_CR41","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/bjc.2016.63","volume":"114","author":"JP Zevallos","year":"2016","unstructured":"Zevallos JP, Mazul AL, Rodriguez N, Weissler MC, Brennan P, Anantharaman D, Abedi-Ardekani B, Neil Hayes D, Olshan AF (2016) Previous tonsillectomy modifies odds of tonsil and base of tongue cancer. Br J Cancer 114(7):832\u2013838","journal-title":"Br J Cancer"},{"issue":"6","key":"870_CR42","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1158\/1055-9965.EPI-15-0907","volume":"25","author":"AK Chaturvedi","year":"2016","unstructured":"Chaturvedi AK, Song H, Rosenberg PS, Ramqvist T, Anderson WF, Munck-Wikland E, Ye W, Dalianis T (2016) Tonsillectomy and incidence of oropharyngeal cancers. Cancer Epidemiol Biomark Prev 25(6):944\u2013950","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"870_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21645515.2016.1140288","volume":"12","author":"HW Chesson","year":"2016","unstructured":"Chesson HW, Markowitz LE, Hariri S, Ekwueme DU, Saraiya M (2016) The impact and cost-effectiveness of nonavalent HPV vaccination in the United States: estimates from a simplified transmission model. Hum Vaccin Immunother 12:1\u201310","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"870_CR44","doi-asserted-by":"publisher","first-page":"e0153106","DOI":"10.1371\/journal.pone.0153106","volume":"11","author":"A van Lier","year":"2016","unstructured":"van Lier A, McDonald SA, Bouwknegt M, Kretzschmar ME, Havelaar AH (2016) Disease burden of 32 infectious diseases in the Netherlands, 2007\u20132011. PLoS One 11(4):e0153106","journal-title":"PLoS one"},{"issue":"4","key":"870_CR45","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/ijc.27713","volume":"132","author":"WA Tjalma","year":"2013","unstructured":"Tjalma WA, Fiander A, Reich O, Powell N, Nowakowski AM, Kirschner B, Koiss R, O\u2019Leary J, Joura EA, Rosenlund M et al (2013) Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. Int J Cancer 132(4):854\u2013867","journal-title":"Int J Cancer"},{"issue":"16","key":"870_CR46","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1016\/j.ejca.2013.06.033","volume":"49","author":"S de Sanjose","year":"2013","unstructured":"de Sanjose S, Alemany L, Ordi J, Tous S, Alejo M, Bigby SM, Joura EA, Maldonado P, Laco J, Bravo IG et al (2013) Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer 49(16):3450\u20133461","journal-title":"Eur J Cancer"},{"issue":"16","key":"870_CR47","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1016\/j.ejca.2014.07.018","volume":"50","author":"L Alemany","year":"2014","unstructured":"Alemany L, Saunier M, Tinoco L, Quiros B, Alvarado-Cabrero I, Alejo M, Joura EA, Maldonado P, Klaustermeier J, Salmeron J et al (2014) Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples. Eur J Cancer 50(16):2846\u20132854","journal-title":"Eur J Cancer"},{"issue":"1","key":"870_CR48","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ijc.28963","volume":"136","author":"L Alemany","year":"2015","unstructured":"Alemany L, Saunier M, Alvarado-Cabrero I, Quiros B, Salmeron J, Shin HR, Pirog EC, Guimera N, Hernandez-Suarez G, Felix A et al (2015) Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer 136(1):98\u2013107","journal-title":"Int J Cancer"},{"issue":"13","key":"870_CR49","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/jnci\/djh183","volume":"96","author":"BJ Braakhuis","year":"2004","unstructured":"Braakhuis BJ, Snijders PJ, Keune WJ, Meijer CJ, Ruijter-Schippers HJ, Leemans CR, Brakenhoff RH (2004) Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 96(13):998\u20131006","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"870_CR50","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.oraloncology.2013.11.004","volume":"50","author":"JD Combes","year":"2014","unstructured":"Combes JD, Franceschi S (2014) Role of human papillomavirus in non-oropharyngeal head and neck cancers. Oral Oncol 50(5):370\u2013379","journal-title":"Oral Oncol"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-017-0870-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-017-0870-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-017-0870-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:06:57Z","timestamp":1744175217000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-017-0870-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,17]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["870"],"URL":"https:\/\/doi.org\/10.1007\/s10552-017-0870-6","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,17]]},"assertion":[{"value":"11 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"JB has received speakers\u2019 fees from Qiagen and consultancy fees from Roche, DDL Diagnostic Laboratory, GlaxoSmithKline and Merck\/SPMSD; all JB\u2019s fees were collected by his employer. The other authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}